DK303887A - Dopamin-beta-hydroxylaseinhibitorer og fremgangsmaade til fremstilling deraf - Google Patents

Dopamin-beta-hydroxylaseinhibitorer og fremgangsmaade til fremstilling deraf

Info

Publication number
DK303887A
DK303887A DK303887A DK303887A DK303887A DK 303887 A DK303887 A DK 303887A DK 303887 A DK303887 A DK 303887A DK 303887 A DK303887 A DK 303887A DK 303887 A DK303887 A DK 303887A
Authority
DK
Denmark
Prior art keywords
dopamine
beta
procedures
preparing
hydroxylase inhibitors
Prior art date
Application number
DK303887A
Other languages
English (en)
Other versions
DK303887D0 (da
Inventor
Pamela Anne Chambers
Lawrence Ivan Kruse
Original Assignee
Smithkline Beckman Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beckman Corp filed Critical Smithkline Beckman Corp
Publication of DK303887D0 publication Critical patent/DK303887D0/da
Publication of DK303887A publication Critical patent/DK303887A/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C57/00Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms
    • C07C57/30Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms containing six-membered aromatic rings
    • C07C57/42Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms containing six-membered aromatic rings having unsaturation outside the rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/40Unsaturated compounds
    • C07C59/58Unsaturated compounds containing ether groups, groups, groups, or groups
    • C07C59/64Unsaturated compounds containing ether groups, groups, groups, or groups containing six-membered aromatic rings
    • C07C59/66Unsaturated compounds containing ether groups, groups, groups, or groups containing six-membered aromatic rings the non-carboxylic part of the ether containing six-membered aromatic rings
    • C07C59/68Unsaturated compounds containing ether groups, groups, groups, or groups containing six-membered aromatic rings the non-carboxylic part of the ether containing six-membered aromatic rings the oxygen atom of the ether group being bound to a non-condensed six-membered aromatic ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02Silicon compounds
    • C07F7/08Compounds having one or more C—Si linkages
    • C07F7/0803Compounds with Si-C or Si-Si linkages
    • C07F7/081Compounds with Si-C or Si-Si linkages comprising at least one atom selected from the elements N, O, halogen, S, Se or Te

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK303887A 1986-06-19 1987-06-15 Dopamin-beta-hydroxylaseinhibitorer og fremgangsmaade til fremstilling deraf DK303887A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US87604386A 1986-06-19 1986-06-19

Publications (2)

Publication Number Publication Date
DK303887D0 DK303887D0 (da) 1987-06-15
DK303887A true DK303887A (da) 1987-12-20

Family

ID=25366874

Family Applications (1)

Application Number Title Priority Date Filing Date
DK303887A DK303887A (da) 1986-06-19 1987-06-15 Dopamin-beta-hydroxylaseinhibitorer og fremgangsmaade til fremstilling deraf

Country Status (6)

Country Link
EP (1) EP0250264A1 (da)
JP (1) JPS6322049A (da)
AU (1) AU7445587A (da)
DK (1) DK303887A (da)
PT (1) PT85081A (da)
ZA (1) ZA874396B (da)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2555167Y2 (ja) * 1989-12-29 1997-11-19 大阪瓦斯株式会社 電気二重層キヤパシタ
AU5671699A (en) * 1998-08-14 2000-03-06 Smithkline Beecham Corporation Grp receptor ligands
CN1946666A (zh) 2004-02-27 2007-04-11 埃姆艮股份有限公司 用于治疗代谢性疾病的化合物、药物组合物和方法
US7465804B2 (en) 2005-05-20 2008-12-16 Amgen Inc. Compounds, pharmaceutical compositions and methods for their use in treating metabolic disorders
AU2006291234A1 (en) 2005-09-14 2007-03-22 Amgen Inc. Conformationally constrained 3- (4-hydroxy-phenyl) - substituted-propanoic acids useful for treating metabolic disorders
EP2061760A1 (en) 2006-09-07 2009-05-27 Amgen, Inc Benzo-fused compounds for use in treating metabolic disorders
CA2662305C (en) 2006-09-07 2012-04-17 Amgen Inc. Heterocyclic gpr40 modulators
EP2139843B1 (en) 2007-04-16 2013-12-25 Amgen, Inc Substituted biphenyl phenoxy-, thiophenyl- and aminophenylpropanoic acid gpr40 modulators
KR20100090249A (ko) 2007-10-10 2010-08-13 암젠 인크 치환된 비페닐 grp40 조절제
JP2011515341A (ja) 2008-03-06 2011-05-19 アムジエン・インコーポレーテツド 代謝障害の治療に有用な立体配座的に制限されたカルボン酸誘導体
EP2358656B1 (en) 2008-10-15 2014-01-01 Amgen, Inc Spirocyclic gpr40 modulators

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE7809127L (sv) * 1978-08-30 1980-03-01 Claesson Alf Allenaminer
CA1242718A (en) * 1983-11-21 1988-10-04 John R. Carson Acetylene derivatives and methods for the treatment of hypertension and angina
US4537974A (en) * 1984-09-26 1985-08-27 Hughes Aircraft Company Diethynylated phenylbenzimidazole compounds

Also Published As

Publication number Publication date
EP0250264A1 (en) 1987-12-23
AU7445587A (en) 1987-12-24
JPS6322049A (ja) 1988-01-29
ZA874396B (en) 1988-04-27
PT85081A (en) 1987-07-01
DK303887D0 (da) 1987-06-15

Similar Documents

Publication Publication Date Title
DK484587D0 (da) Antioxidant og fremgangsmaade til fremstilling heraf
DK664887D0 (da) 3-substituerede 3-aroyloxy-propanaminer og fremgangsmaade til fremstilling deraf
DK8787D0 (da) Indolderivater og fremgangsmaade til fremstilling deraf
DK554685D0 (da) Renininhiberende dipeptider og fremgangsmaade til fremstilling deraf
DK493882A (da) Faeldningskiselsyre og fremgangsmaade til fremstilling deraf
DK301886D0 (da) Furanon-derivater og fremgangsmaade til fremstilling heraf
DK521887D0 (da) Substituerede pyrazoliner og fremgangsmaade til fremstilling deraf
DK157683A (da) N-phosphonomethylglycinderivater og fremgangsmaade til fremstilling og anvendelse deraf
DK315085D0 (da) Isoinsolinyl-alkyl-piperaziner og fremgangsmaade til fremstilling deraf
DK303887A (da) Dopamin-beta-hydroxylaseinhibitorer og fremgangsmaade til fremstilling deraf
DK477287A (da) Pyrido-benzoxadiazin-derivater og fremgangsmaade til fremstilling deraf
DK251087A (da) Dopamin-beta-hydrolaseinhibitorer og fremgangsmaade til fremstilling deraf
DK362987D0 (da) Hexahydroarylquinolizin og fremgangsmaade til fremstilling deraf
DK401385A (da) 7-oxomitosan-derivater og fremgangsmaade til fremstilling deraf
DK515686A (da) Dopamin-beta-hydroxylase-inhibitorer og fremgangsmaade til fremstillingderaf
DK487688D0 (da) Benzofuranderivater og fremgangsmaade til fremstilling deraf
DK446685D0 (da) Carbapenemderivater og fremgangsmaade til fremstilling deraf
DK624588D0 (da) 4-demethoxy-anthracyclin-derivater og fremgangsmaade til fremstilling deraf
DK129689D0 (da) Ifosfamid-mesna-lyofilisat og fremgangsmaade til fremstilling deraf
DK62086D0 (da) Dopamin-beta-hydroxylase inhibitorer og fremgangsmaade til fremstilling deraf samt midler indeholdende inhibitorerne
DK182585D0 (da) Fosfomycinderivat og fremgangsmaade til fremstilling deraf
DK112682A (da) Azaspiroalkandioner og fremgangsmaade til fremstilling deraf
DK319188A (da) Glycerolacetalaminoacylat og fremgangsmaade til fremstilling deraf
DK287787D0 (da) Isoxazolidinonderivater og fremgangsmaade til fremstilling deraf
NO170761C (no) Askorbat-2-polyfosfatforbindelser og fremgangsmaate til fremstilling derav

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment